Évaluation de la couverture thérapeutique de la campagne de traitement de masse contre la filariose lymphatique dans deux districts sanitaires au Burkina Faso

BACKGROUND & RATIONALE: Burkina Faso has been implementing preventive chemotherapy against lymphatic filariasis since 2001. While 61 health districts (HDs) have stopped mass drug administration (MDA), transmission persists in 9 HDs despite good reported MDA coverage. To validate the reported cov...

Descripción completa

Detalles Bibliográficos
Autores principales: SERME, Mamadou, ZIDA, Adama, BOUGMA, Roland, KIMA, Appolinaire, NASSA, Christophe, OUEDRAOGO, Micheline, KABRE, Cathérine, ZOROMÉ, Harouna, GUIRE, Issa, NARE, Dieudonné, BOUGOUMA, Clarisse
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MTSI 2022
Materias:
Santé Publique
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9940276/
https://www.ncbi.nlm.nih.gov/pubmed/36815181
http://dx.doi.org/10.48327/mtsi.v2i4.2022.174

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9940276/
https://www.ncbi.nlm.nih.gov/pubmed/36815181
http://dx.doi.org/10.48327/mtsi.v2i4.2022.174

Ejemplares similares